Menlo therapeutics inc. (MNLO)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Dec'16
Assets
CURRENT ASSETS:
Cash and cash equivalents

57,601

43,759

34,244

65,055

61,958

49,510

70,196

73,584

78,527

10,206

4,027

Restricted cash

855

825

-

-

-

-

-

-

-

-

-

Short term bank deposits

-

12,102

-

-

-

-

-

-

-

-

-

Investment in marketable securities (Note 6)

23,790

16,246

-

-

-

-

-

-

-

-

-

Restricted investment in marketable securities (Note 6)

421

434

-

-

-

-

-

-

-

-

-

Short-term investments

-

-

57,112

44,355

59,558

86,740

82,461

80,171

77,310

49,295

26,881

Trade receivable

8,333

135

-

-

-

-

-

93

234

786

0

Prepaid and other assets

4,236

1,557

2,073

3,717

3,706

3,250

1,811

2,315

3,587

3,574

632

Inventory (Note 7)

3,205

1,356

-

-

-

-

-

-

-

-

-

TOTAL CURRENT ASSETS

98,441

76,414

93,429

113,127

125,222

139,500

154,468

156,163

159,658

63,861

31,540

NON-CURRENT ASSETS:
Long-term investments

-

-

2,004

-

-

-

-

10,425

20,713

2,978

10,420

Property and equipment, net

2,834

2,885

113

128

143

146

136

22

25

28

27

Operating lease right-of-use assets (Note 10)

1,721

1,694

830

985

670

-

-

-

-

-

-

In-process research & development (Note 3)

50,300

-

-

-

-

-

-

-

-

-

-

Goodwill (Note 3)

4,045

-

-

-

-

-

-

-

-

-

-

Other long-term assets

-

-

-

-

-

-

354

306

83

-

-

Prepaid and other assets

3,192

166

200

144

223

282

-

-

-

-

66

TOTAL NON-CURRENT ASSETS

62,092

4,745

-

-

-

-

-

-

-

-

-

TOTAL ASSETS

160,533

81,159

96,576

114,384

126,258

139,928

154,958

166,916

180,479

66,867

42,053

Liabilities and shareholders' equity
CURRENT LIABILITIES:
Trade payables

14,114

19,352

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

2,992

4,704

3,782

3,290

2,702

5,089

3,501

2,462

1,526

Accrued expenses

12,452

3,381

5,719

6,487

6,161

6,254

5,360

3,560

3,174

3,559

581

Employee related obligations

7,803

5,231

-

-

-

-

-

-

-

-

-

Operating lease liabilities (Note 10)

1,009

1,092

-

-

-

-

-

-

-

-

-

Derivative liabilities

1,190

-

-

-

-

-

-

-

-

-

-

Contingent Stock Right (Note 3)

19,636

-

-

-

-

-

-

-

-

-

-

Other

382

270

-

-

-

-

-

-

-

-

-

Lease liability

-

-

741

715

684

-

-

-

-

-

-

Deferred revenue, current

-

-

-

-

-

-

-

-

1,796

1,796

1,796

TOTAL CURRENT LIABILITIES

56,586

29,326

9,452

11,906

10,627

9,544

8,062

8,649

8,471

7,817

3,903

LONG-TERM LIABILITIES:
Liability for employee severance benefits

411

424

-

-

-

-

-

-

-

-

-

Operating lease liabilities (Note 10)

727

653

122

301

-

-

-

-

-

-

-

Long-term debt (Note 8)

32,818

32,725

-

-

-

-

-

-

-

-

-

Other liabilities

456

456

-

-

-

-

-

-

-

-

-

TOTAL LONG-TERM LIABILITIES

34,412

34,258

-

-

-

-

-

-

-

-

-

Deferred revenue, long-term

-

-

-

-

-

-

-

-

6,286

6,735

8,531

Other non-current liabilities

-

-

-

-

-

7

12

78

20

22

57

TOTAL LIABILITIES

90,998

63,584

9,574

12,207

10,627

9,551

8,074

8,727

14,777

14,574

12,491

COMMITMENTS (Note 11)

-

-

-

-

-

-

0

0

0

-

0

STOCKHOLDERS' EQUITY:
Preferred stock: $0.0001 par value; 20,000,000 shares and no shares authorized at December 31, 2019 and 2018, respectively; no shares issued and outstanding at December 31, 2019 and 2018, respectively

-

-

-

-

-

-

0

0

0

-

-

Common stock: $0.0001 par value; 300,000,000 shares authorized at March 31, 2020 and December 31, 2019, respectively; 61,501,130 and 36,480,314 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

6

3

3

3

3

3

3

3

3

1

1

Additional paid-in capital

-

-

249,805

248,155

245,147

241,106

240,024

238,530

-

2,207

-

Additional paid-in capital

420,430

328,154

-

-

-

-

-

-

237,749

-

699

Accumulated deficit

-350,861

-310,587

-162,841

-145,986

-129,509

-110,636

-93,042

-80,194

-71,848

-59,191

-30,115

Accumulated other comprehensive income (loss)

-40

5

35

5

-10

-96

-101

-150

-202

-51

-26

TOTAL SHAREHOLDERS' EQUITY

69,535

17,575

87,002

102,177

115,631

130,377

146,884

158,189

165,702

-57,034

-29,441

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

160,533

81,159

96,576

114,384

126,258

139,928

154,958

166,916

180,479

66,867

42,053

Series A Convertible Preferred Stock
Convertible preferred stock

-

-

-

-

-

-

-

-

-

14,183

-

Series B Convertible Preferred Stock
Convertible preferred stock

-

-

-

-

-

-

-

-

-

44,820

-

Series C Convertible Preferred Stock
Convertible preferred stock

-

-

-

-

-

-

-

-

-

50,324

-